Altamira Therapeutics Ltd - Warrants (29/03/2028) Current Cash

The latest current cash for CYTOW is $1M as of December 2024. That compares with $620K in the prior-year period — up 61.7% year over year. Investors often review this figure alongside Altamira Therapeutics Ltd - Warrants (29/03/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CYTOW's current cash moved from $620K to $1M — a 61.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Altamira Therapeutics Ltd - Warrants (29/03/2028)'s operating scale or balance-sheet position.

A current cash figure of $1M for CYTOW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CYTOW's current cash ($1M), review year-over-year change from $620K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Altamira Therapeutics Ltd - Warrants (29/03/2028)'s current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.